ArticleAmerican journal of cancer research2018

Trametinib suppresses chemotherapy-induced cold and mechanical allodynia via inhibition of extracellular-regulated protein kinase 1/2 activation.

Masanobu Tsubaki et al.PubMed ↗Full text ↗

No numbers read from the abstract.